Inhibitory effect of Fuzheng Yiliuyin in combination with chemotherapeutics on human gastric carcinoma cell strain

Table 1 Effects of ZY in combination with chemotherapeutics on SGC-7901 MGC–803 cell proliferation (mean±SD)

Group	SGC-7901			MGC–803
	24 h	48 h	72 h	24 h	48 h	72 h
ZY	12.4 ± 7.9	17.4 ± 3.1	20.1 ± 5.5	8.9 ± 4.5	11.8 ± 5.4	14.8 ± 2.7
ZY + Vp-16	a51.2 ± 4.2	e56.9 ± 4.8	c62.3 ± 3.9	g36.9 ± 7.2	i48.9 ± 5.2	k58.8 ± 4.6
ZY + ADM	a46.5 ± 7.2	e50.1 ± 3.2	c55.4 ± 48	g34.5 ± 8.1	i43.6 ± 3.7	k50.7 ± 6.4
ZY + 5-Fu	a57.8 ± 2.6	e61.9 ± 6.3	c69.9 ± 8.4	g40.7 ± 6.6	i50.8 ± 4.7	k55.7 ± 3.2
ZY + DDP	a53.6 ± 2.4	e58.4 ± 1.7	c67.4 ± 5.7	g70.2 ± 3.5	i80.1 ± 3.6	k84.3 ± 7.5
ZY + EAP	a61.2 ± 3.3	e68.5 ± 3.9	c71.5 ± 3.4	g73.8 ± 4.6	i72.2 ± 4.1	k74.9 ± 3.4
ZY + EFP	a79.4 ± 2.8	e83.3 ± 4.8	c87.5 ± 4.3	g82.6 ± 7.8	i87.5 ± 3.1	k89.9 ± 4.8

^aP < 0.05 vs 24 h,

^cP < 0.05 vs 48 h,

^eP < 0.05 vs 72 h,

^gP < 0.05 vs 24 h,

ⁱP < 0.05 vs 42 h,

^kP < 0.05 vs 72 h.